Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas

Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

(2010) Alexa B. Turke et al.   CANCER CELL

LRRK2G2019S mutations are associated with an increased cancer risk in Parkinson disease

(2010) Rachel Saunders-Pullman et al.   MOVEMENT DISORDERS

Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors

(2009) Michalis V Karamouzis et al.   LANCET ONCOLOGY

Identification of copy number alterations and its association with pathological features in clear cell and papillary RCC

(2008) Daisuke Matsuda et al.   CANCER LETTERS

Identification of Genes Differentially Expressed in Benign versus Malignant Thyroid Tumors

(2008) N. B. Prasad et al.   CLINICAL CANCER RESEARCH

Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation

(2008) Stéphanie Kermorgant et al.   JOURNAL OF CELL BIOLOGY

Autophagic cell death: the story of a misnomer

(2008) Guido Kroemer et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY